Premium
IC‐P‐183: PET IMAGING OF SYNAPTIC DENSITY (SYNAPTIC VESICLE GLYCOPROTEIN 2A, SV2A) IN ALZHEIMER'S DISEASE: INITIAL EXPERIENCE
Author(s) -
Mecca Adam P.,
Chen Ming-Kai,
Naganawa Mika,
Finnema Sjoerd J.,
Toyonaga Takuya,
Lin Shu-fei,
Gallezot Jean-Dominique,
McDonald Julia W.,
Michalak Hannah R.,
Nabulsi Nabeel B.,
Huang Yiyun,
Arnsten Amy F.T.,
Carson Richard E.,
Dyck Christopher H.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2250
Subject(s) - pittsburgh compound b , positron emission tomography , nuclear medicine , medicine , dementia , alzheimer's disease , binding potential , hippocampal formation , fluorodeoxyglucose , pathology , cardiology , neuroscience , psychology , disease
each EBM stage. Proportion of negative scans in dark blue and positive scans in green. Each EBM stage on the x-axis corresponds to the occurrence of a new regional transition event. Stage 0 corresponds to no events having occurred and stage 20 is when all events have occurred. Events are ordered by the maximum likelihood event sequence for the whole population as shown in Figure 1. Poster Presentations: Saturday, July 21, 2018 P152